Cerebral Blood Flow Measurements by Near

Infrared Spectrophotometry in Reflectance Mode
Are Valid in Neonates
To the Editor: Newton et al. (1997) state in their abstract and con-J Cereh Blood Flow Metab. Vol. 18, No.6, 1998 clusion that the current method of measuring CBF by near infrared spectrophotometry (CBFN1Rs) in the reflec tance mode is inaccurate. It is misleading to emphasize the difference between reflectance and transmission NIRS. The scattering of light at the head is very strong. Therefore, after a short distance, we measure only scat tered light whether the detector is fixed on the same side of the head as the emitter or on the opposite. Contrary to what Newton et al. (1997) state, the study by Skov et al. (1991) was actually performed in reflectance with an interoptode distance of 4 to 5 cm. Thus measuring cere bral blood flow in neonates has been validated for re flectance as well as transmission (Bucher et al. 1993) measurements. Even the finding that NIRS overestimates cerebral blood flow compared to the xenon clearance method in Bucher's study and underestimates it in Sk ov's study has been explained by the different methods of evaluating the data (Wolf et al. 1996) . This proves that in neonates both reflection and transmission NIRS are valid for measuring cerebral blood flow and doubts about this are difficult to justify by a geometrically consider ably different animal model. Furthermore, it previously has been shown in adults that as the layers surrounding the brain are thicker and hence the proportion of the path the light spends in these higher, the cerebral blood flow values measured by NIRS can no longer be attributed solely to the brain (Owen Reece et al. 1996) . However, reasonable values were obtained, when the optodes were put directly on the dura measuring reflectance.
Hence the crucial point is: What are the optical prop erties of these layers? What is the proportion of the total path of light spent in these layers? Consequently, we would have expected more geometrical information about dogs, such as thickness of the cranium, CSF layer, and brain geometry.
It has previously been shown (Wolf et al. 1996 ) that the test-retest variability increases considerably, if the sample rate is lowered. Thus the high test-retest variabil ity of Newton et al. (1997) can be attributed to the sample rate, which was too low compared to the short transit time in dogs. Only five samples were used for the calculations of the oxygenation increase. Using an ap propriate sample rate as well as equipment with low noise, it is possible to reach test-retest variabilities below 20% (Skov et al. 1991; Bucher et al. 1993; Wolf et al. 1996) .
In our experience the proportion of the measurements, which have to be rejected, depends on the skill of the person performing the measurements, especially the 31.3% of the measurements, which were not acceptable because of baseline problems with the arterial oxygen saturation. Even though we used conventional pulse ox imetry to determine arterial oxygen saturation, which certainly is one of the weak spots of this method, we only had to reject approximately 50% of the measurements (Wolf et al. 1996) .
In conclusion, NIRS is a valid and feasible method to measure cerebral blood flow, if it is used in the appro priate way.
Martin Wolf Oskar Baenziger
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Authors' Reply
To the Editor:
We thank Wolf and colleagues for their comments concerning our article (Newton et aI., 1997) and address their comments.
The complete statement, quoted from our manuscript, was "In conclusion, NIRS detects blood flow in the brain in most subjects, but measurement of CBFN J RS in the reflectance mode, using oxygen as an intravascular tracer is inaccurate, particularly at high CBF values." We were concerned not only about bias and linearity, but also the large test-retest variability encountered in the study. Variability of the magnitude encountered in our study is unacceptable for a clinical measurement. How ever, the authors do raise interesting questions regarding the source of this variability.
What is the primary source of error in the O2 CBF N 1RS technique, as applied to adults, children, and larger ani mal models? Is it attributable to the mode used to acquire information about the tracer (hemoglobin); the influence of the layers, through which light must pass, on it's in formation content; or is it technical error attributable to an inability to adequately characterize the information contained in the Hb and Hb02 transients within a single transit time? We believe all of these factors are involved.
The fact that our results correlate better at lower How rates compared to higher flow rates regardless of geo metrical considerations indicates a problem specific to short transit times of tracer through the brain. We agree with Wolf and colleagues that faster sampling with the same or better signal to noise would be an improvement, though this was limited by the NIRS instrument used in our study (NIRO 500, Hamamatsu Photonics, Hama matsu, Japan). However, a more important factor at short transit times is the tracer-input function which, with the O2 method, is limited by the speed with which alveolar P02 can be increased. Pulmonary and hemodynamic problems may constrain the range over which both the magnitude and rate of increase of Hb02 can be forced. Spontaneous changes in ventilation can exert secondary influences on flow, independent of oxygen, via carbon dioxide, and blood pressure may be unstable in some patients. At adult CBF values, it may be necessary to use bolus injections of indocyanine green to obtain rapid tracer increases in 1 to 2 seconds, as shown recently by Roberts et aI., 1998) .
In addition, we showed that using O2 as a tracer does lead to changes in CBF itself as measured by total cere bral venous outflow. The observed variability of this ef fect is likely to result in increased test-retest variability and bias. Again, using an inert tracer such as indocyan i ne green would reduce this problem.
The terms "reHectance mode" and "transmission mode" are relevant but do not fully explain all the im portant anatomical differences between our animal study, as a model of an adult or child study, and the previous human neonate validations. In the newborn study the head is smaller, and the optodes tend to be 1-2 cm fur ther apart. Hence, the angle between source and detector is nearer "transmission" in the newborn and nearer "re flectance" in the adult. Other important characteristics are that the extracerebral tissues (skin and skull) are sig nificantly thinner and more transparent (less scattering) and the white matter is less scattering in the newborn compared to the human adult, human child, and adult dog. All these factors lead to better sampling of the gray matter relative to extracerebral tissues in the newborn. Perhaps it would have been better to use the terms "adult" and "neonatal" mode instead of "reflectance" and "transmission". The major effect of these anatomi cal differences is their affect on the bias of the NIRS technique compared to microspheres. Of greater concern is the effect that the clear CSF layer might have on the measurement which is significantly less predictable than the other issues (Okada and Delpy, 1996; Okada et aI, 1997) . It is reasonable to say that potentially, channeling
